Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Merck & Co. designs new protein kinase inhibitors

Jan. 27, 2012

Vertex Pharmaceuticals patents new serine/threonine-protein kinase ATR inhibitors

Jan. 27, 2012

Recruitment begins in phase Ib/II U3-1287 combination study

Jan. 27, 2012

Cephalon scientists disclose synthesis, pharmacological and first clinical data on CEP-11981

Jan. 27, 2012

Liposomal irinotecan shows benefit in metastatic colorectal cancer

Jan. 27, 2012

Phase III afatinib trials begin in head and neck cancer

Jan. 26, 2012

Spectrum Pharmaceuticals enters licensing agreement for Zevalin

Jan. 26, 2012

Panobinostat trial in colorectal cancer yields mixed results

Jan. 26, 2012

Kampo medicine reduces oxaliplatin-induced peripheral neuropathy in patients with cancer

Jan. 26, 2012

Cancer vaccine shows activity in phase I/II trial

Jan. 26, 2012

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...